HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector

被引：62

作者：

Anderson J. ^{[1
]}

Akkina R. ^{[1
]}

机构：

[1] Dept. Microbiology Immunology and Pathology, Colorado State University, Fort Collins

来源：

AIDS Research and Therapy | / 2卷 / 1期

关键词：

Bispecific lentiviral vector; CCR5; siRNA; CXCR4; HIV-1; co-receptors; HIV/AIDS gene therapy;

D O I：

10.1186/1742-6405-2-1

中图分类号：

学科分类号：

摘要：

Background: RNA interference (RNAi) mediated by small interfering RNAs (siRNAs) has proved to be a highly effective gene silencing mechanism with great potential for HIV/AIDS gene therapy. Previous work with siRNAs against cellular coreceptors CXCR4 and CCR5 had shown that down regulation of these surface molecules could prevent HIV-1 entry and confer viral resistance. Since monospecific siRNAs targeting individual coreceptors are inadequate in protecting against both T cell tropic (X4) and monocyte tropic (R5) viral strains simultaneously, bispecific constructs with dual specificity are required. For effective long range therapy, the bispecific constructs need to be stably transduced into HIV-1 target cells via integrating viral vectors. Results: To achieve this goal, lentiviral vectors incorporating both CXCR4 and CCR5 siRNAs of short hairpin design were constructed. The CXCR4 siRNA was driven by a U6 promoter whereas the CCR5 siRNA was driven by an HI promoter. A CMV promoter driven EGFP reporter gene is also incorporated in the bispecific construct. High efficiency transduction into coreceptor expressing Magi and Ghost cell lines with a concomitant down regulation of respective coreceptors was achieved with lentiviral vectors. When the siRNA expressing transduced cells were challenged with X4 and R5 tropic HIV-1, they demonstrated marked viral resistance. HIV-1 resistance was also observed in bispecific lentiviral vector transduced primary PBMCs. Conclusions: Both CXCR4 and CCR5 coreceptors could be simultaneously targeted for down regulation by a single combinatorial lentiviral vector incorporating respective anti-coreceptor siRNAs. Stable down regulation of both the coreceptors protects cells against infection by both X4 and R5 tropic HIV-1. Stable down regulation of cellular molecules that aid in HIV-1 infection will be an effective strategy for long range HIV gene therapy. © 2005 Anderson and Akkina; licensee BioMed Central Ltd.

引用

共 53 条

[1] Malim M.H., Freimuth W.W., Liu J., Boyle T.J., Lyerly H.K., Cullen B.R., Nabel G.J., Stable expression of transdominant rev protein in human T cells inhibits Human Immunodeficiency Virus replication, J Exp Med, 176, pp. 1197-1201, (1992)
[2] Bonyhadi M.L., Moss K., Voytovich A., Auten J., Kalfoglou C., Plavec I., Forestell S., Su L., Bohnlein I., Kaneshima H., RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication, J Virol, 71, pp. 4707-4716, (1997)
[3] Ding S.F., Lombardi R., Nazari R., Joshi S., A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and transdominant negative mutant Gag and Env proteins, Front Biosci, 7, (2002)
[4] Michienzi A., Li S., Zaia J.A., Rossi J., A nucleolar TAR decoy inhibitor of HIV-1 replication, Proc Natl Acad Sci, 99, pp. 14047-14052, (2002)
[5] Akkina R., Banerjea A., Bai J., Anderson J., Li M.J., Rossi J., siRNAs, ribozymes, and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS, Anticancer Res, 23, pp. 1997-2006, (2003)
[6] Bahner I., Kearns K., Hao Q.L., Smogorzewska E.M., Kohn D.B., Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type I replication in myelomonocytic cells produced in long-term culture, J Virol, 70, pp. 4352-4360, (1996)
[7] Lisziewicz J., Sun D., Smythie J., Lusso P., Lori F., Louie A., Markham P., Rossi J., Reitz M., Gallo R.C., Inhibition of human immunodeficiency virus type I replication by regulated expression of a polymeric tat activation response RNA decoy as a strategy for gene therapy in AIDS, Proc Natl Acad Sci USA, 90, pp. 8000-8004, (1993)
[8] Bai J., Gorantla S., Banda N., Cagnon L., Rossi J., Akkina R., Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo, Mol Ther, 1, pp. 244-254, (2000)
[9] Bai J., Rossi J., Akkina R., Multivalent anti-CCR5 ribozymes for stem cell-based HIV type I gene therapy, AIDS Res Hum Retroviruses, 17, pp. 385-399, (2001)
[10] Bai J., Banda N., Lee N.S., Rossi J., Akkina R., RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model, Mol Ther, 6, pp. 770-782, (2002)

← 1 2 3 4 5 6 →